IDT Australia Limited (ASX:IDT)
0.0650
0.00 (0.00%)
Sep 9, 2025, 12:28 PM AEST
IDT Australia Revenue
In the fiscal year ending June 30, 2025, IDT Australia had annual revenue of 19.77M AUD with 40.99% growth. IDT Australia had revenue of 9.28M in the half year ending June 30, 2025, with 103.75% growth.
Revenue
19.77M
Revenue Growth
+40.99%
P/S Ratio
1.41
Revenue / Employee
197.65K
Employees
100
Market Cap
27.87M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 19.77M | 5.75M | 40.99% |
Jun 30, 2024 | 14.02M | 7.03M | 100.67% |
Jun 30, 2023 | 6.99M | -5.14M | -42.41% |
Jun 30, 2022 | 12.13M | -4.80M | -28.34% |
Jun 30, 2021 | 16.93M | 2.76M | 19.46% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |